Yassi N.Zhao H.Churilov L.Campbell B.C.V.Wu T.Ma H.Cheung A.Kleinig T.Brown H.Choi P.JIANN-SHING JENGRanta A.Wang H.-K.Cloud G.C.Grimley R.Shah D.Spratt N.Cho D.-Y.Mahawish K.Sanders L.Worthington J.Clissold B.Meretoja A.Yogendrakumar V.Ton M.D.Dang D.P.Phuong N.T.M.Nguyen H.-T.Hsu C.Y.Sharma G.Mitchell P.J.Yan B.Parsons M.W.Levi C.Donnan G.A.Davis S.M.2022-09-062022-09-06202220598696https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124195965&doi=10.1136%2fsvn-2021-001070&partnerID=40&md5=6ea8c7c12b8584a461557db0bf7f8342https://scholars.lib.ntu.edu.tw/handle/123456789/617805[SDGs]SDG3Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trialjournal article10.1136/svn-2021-001070348485662-s2.0-85124195965